Friday, July 10, 2026
🇺🇸 FDA

Intelligence · INN directory

Pharmaceutical Drugs

Regulatory status, brand names, and pipeline context for BD, medical affairs, and competitive intelligence teams.

Drugs indexed 4,798
Companies 1,771
Pipeline programs 20,548

Quick answer

NovaPharmaNews tracks 4,798 pharmaceutical drugs by INN (International Nonproprietary Name), with US FDA approval status, brand names, originators, routes of administration, and links to pipeline programs and patents. Search by generic name or browse A–Z for competitive intelligence and medical affairs reference.

Recently updated

FDA-approved

Showing page 12 of 200 · By data quality, then INN

  1. dexamethasone sodium phosphate

    DEXAMETHASONE SODIUM PHOSPHATE Amneal Pharma Europe Ltd

    OPHTHALMIC, OTIC FDA: approved

  2. dexlansoprazole

    DEXLANSOPRAZOLE Takeda

    ORAL FDA: approved

  3. dexmedetomidine hydrochloride

    PRECEDEX PARTIAL CHANGE APPROVAL Regeneron Ireland Designated Activity Company (DAC)

    BUCCAL, SUBLINGUAL FDA: approved · PMDA: approved

  4. dexmethylphenidate hydrochloride

    DEXMETHYLPHENIDATE HYDROCHLORIDE Teva Pharma GmbH

    ORAL FDA: approved

  5. dextroamphetamine sulfate

    DEXEDRINE Teva Pharma GmbH

    ORAL FDA: approved

  6. dextromethorphan hydrobromide

    NUEDEXTA Amneal Pharma Europe Ltd

    ORAL FDA: approved · EMA: withdrawn

    N07XX59

  7. dextromethorphan polistirex

    DEXTROMETHORPHAN POLISTIREX Amneal Pharma Europe Ltd

    ORAL FDA: approved

  8. dextrose

    DEXTROSE 60% IN PLASTIC CONTAINER Regeneron Ireland Designated Activity Company (DAC)

    INJECTION FDA: approved

  9. diazepam

    ANTENEX 2 Orion Laboratories Pty.

    BUCCAL FDA: approved · TGA: approved

  10. diazoxide

    DIAZOXIDE Teva Pharma GmbH

    INJECTION FDA: approved

  11. diazoxide choline

    VIOKAT SOLENO THERAPEUTICS INC

    ORAL FDA: approved · EMA: application withdrawn

    N07X

  12. dichlorphenamide

    ORMALVI Xeris Biopharma Holdings

    ORAL FDA: approved

  13. diclofenac potassium

    DICLOFENAC POTASSIUM Teva Pharma GmbH

    ORAL FDA: approved

  14. diclofenac sodium

    DICLOFENAC SODIUM Amneal Pharma Europe Ltd

    OPHTHALMIC FDA: approved

  15. dicloxacillin sodium

    PATHOCIL Teva Pharma GmbH

    ORAL FDA: approved

  16. dicyclomine hydrochloride

    DICYCLOMINE HYDROCHLORIDE Regeneron Ireland Designated Activity Company (DAC)

    INJECTION FDA: approved

  17. diethylpropion hydrochloride

    TENUATE Teva Pharma GmbH

    ORAL FDA: approved

  18. diflunisal

    ATTROGY Teva Pharma GmbH

    ORAL FDA: approved · EMA: approved

    N02BA11

  19. difluprednate

    DIFLUPREDNATE Amneal Pharma Europe Ltd

    OPHTHALMIC FDA: approved

  20. dihydroergotamine mesylate

    DIHYDROERGOTAMINE MESYLATE Amneal Pharma Europe Ltd

    INJECTION FDA: approved

  21. diltiazem hydrochloride

    DILACOR XR Teva Pharma GmbH

    INJECTION FDA: approved

  22. dimenhydrinate

    DIMENHYDRINATE Teva Pharma GmbH

    INJECTION FDA: approved

  23. dimethyl fumarate

    APO-DIMETHYL FUMARATE Biogen

    ORAL FDA: approved · EMA: approved · TGA: approved

    L04AX07

  24. dinutuximab

    UNITUXIN United Therapeutics Europe Ltd

    INTRAVENOUS FDA: approved · EMA: withdrawn

    L01FX06

Frequently asked questions

What is the NovaPharmaNews drugs directory?

It is a searchable index of 4,798 pharmaceutical active ingredients and their marketed profiles — INN, brand names, US regulatory status, manufacturers, and cross-links to clinical pipeline and patent records.

Where does drug approval data come from?

Profiles combine FDA Drugs@FDA and Orange Book references, ClinicalTrials.gov pipeline links, and editorial enrichment. See our data sources page for attribution and update cadence. This directory is for professional reference, not medical advice.

How do I find a drug by brand name?

Use the search box on this page — it matches both INN (generic name) and slug. Brand names appear on each drug row and on the full drug profile page, with links to the originator company when available.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.